Preview: Kairos Pharma, Ltd Set To IPO Tomorrow

+0.23%

Kairos Pharma, Ltd.

KAPA

0.74

+0.23%

Kairos Pharma, Ltd (NASDAQ:KAPA) IPO will take place September, 12 on the NASDAQ exchange under the ticker KAPA.

The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on March 11, 2025.

See also: Benzinga IPO Calendar

About Kairos Pharma, Ltd

Kairos Pharma, Ltd is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.